RIL
AKBA icon

Rothschild Investment LLC’s Akebia Therapeutics AKBA Stock Holding History

Rothschild Investment LLC’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.5K Buy
2,195
+2,031
+1,238% +$2.42K ﹤0.01% 2660
2026
Q1 		$228 Buy
164
+163
+16,300% +$224 ﹤0.01% 3281
2025
Q4 		$2 Sell
1
-389
-100% -$814 ﹤0.01% 3418
2025
Q3 		$1.06K Sell
390
-200
-34% -$665 ﹤0.01% 2545
2025
Q2 		$2.15K Buy
590
+485
+462% +$1.33K ﹤0.01% 2029
2025
Q1 		$202 Buy
+105
New +$214 ﹤0.01% 2847

Other funds holding AKBA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Rothschild Investment LLC's AKBA Position: Q2 2026 in Review

Rothschild Investment LLC increased its Akebia Therapeutics (AKBA) stake by 1,238% in Q2 2026, buying an estimated $2.42K and bringing the position to 2,195 shares worth $2.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2660.

Rothschild Investment LLC first reported a position in AKBA in Q1 2025 and has held it in 6 quarters since. 170 funds tracked by Wall St. Rank hold AKBA as of Q2 2026.

  • Rothschild Investment LLC held 2,195 shares of Akebia Therapeutics worth $2.5K as of Q2 2026.
  • Rothschild Investment LLC bought 2,031 Akebia Therapeutics shares in Q2 2026, an estimated $2.42K.
  • Akebia Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2660 holding.
  • Rothschild Investment LLC first reported a position in Akebia Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 170 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.